Similar articles

• Mupirocin in the treatment of impetigo. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

  [No authors listed] [No authors listed] CMAJ. 1990 Mar 15;142(6):543-4. CMAJ. 1990. PMID: 2107019 Free PMC article. Review. No abstract available.
• Topical antibiotic treatment of impetigo with mupirocin.

  Eells LD, Mertz PM, Piovanetti Y, Pekoe GM, Eaglstein WH. Eells LD, et al. Arch Dermatol. 1986 Nov;122(11):1273-6. Arch Dermatol. 1986. PMID: 3096221 Clinical Trial.
• Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.

  Mertz PM, Marshall DA, Eaglstein WH, Piovanetti Y, Montalvo J. Mertz PM, et al. Arch Dermatol. 1989 Aug;125(8):1069-73. Arch Dermatol. 1989. PMID: 2502950 Clinical Trial.
• Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.

  Johnston C. Johnston C. J Am Acad Dermatol. 1991 May;24(5 Pt 1):797-8. doi: 10.1016/s0190-9622(08)80382-9. J Am Acad Dermatol. 1991. PMID: 1907980 No abstract available.
• Mupirocin: a topical antibiotic with a unique structure and mechanism of action.

  Parenti MA, Hatfield SM, Leyden JJ. Parenti MA, et al. Clin Pharm. 1987 Oct;6(10):761-70. Clin Pharm. 1987. PMID: 3146455 Review.